Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy

To perform systematic assessment of ovarian reserve markers using a combination of tests in juvenile systemic lupus erythematosus (JSLE) patients without amenorrhoea. Twenty-seven consecutive JSLE female patients and 13 healthy controls without amenorrhoea were evaluated for 6 months. Ovarian reserv...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical and experimental rheumatology Vol. 30; no. 3; pp. 445 - 449
Main Authors:	AIKAWA, N. E, SALLUM, A. M. E, PEREIRA, R. M. R, SUZUKI, L, VIANA, V. S. T, BONFA, E, SILVA, C. A
Format:	Journal Article
Language:	English
Published:	Pisa Clinical and Experimental Rheumatology 01-05-2012
Subjects:	Adolescent Anti-Mullerian Hormone - blood Antirheumatic Agents - administration & dosage Antirheumatic Agents - adverse effects Biological and medical sciences Child Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Diseases of the osteoarticular system Estradiol - blood Female Follicle Stimulating Hormone - blood Humans Inhibins - blood Lupus Erythematosus, Systemic - blood Lupus Erythematosus, Systemic - drug therapy Lupus Erythematosus, Systemic - physiopathology Luteinizing Hormone - blood Medical sciences Menarche - drug effects Menarche - physiology Ovarian Diseases - blood Ovarian Diseases - chemically induced Ovarian Diseases - physiopathology Ovary - drug effects Ovary - physiology Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Young Adult Human Antineoplastic agent Hormone Immunopathology Connective tissue disease Skin disease Rheumatology juvenile systemic lupus erythematosus Autoimmune disease anti-Müllerian hormone ovarian reserve Ovary Cyclophosphamide Systemic lupus erythematosus Treatment Systemic disease Adolescent Mullerian duct inhibin A inhibin B
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!